Research Interests
Treatment of Myasthenia Gravis and Lambert-Eaton myasthenia
Selected Grants
Defining the clinical phenotype and immunopathology of seronegative MG
ResearchKey Faculty · Awarded by Myasthenia Gravis Foundation · 2021 - 2023Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2017 - 2022Real World Outcomes of Surgical and Medical Management in Myasthenia Gravis
ResearchMentor · Awarded by American Academy of Neurology · 2019 - 2022AANEM Autoimmune Neuromuscular Disorders Fellowship
FellowshipAdvisor · Awarded by AANEM Foundation for Research & Education · 2017 - 2018PCORI Study Investigator Meeting
ConferencePrincipal Investigator · Awarded by Myasthenia Gravis Foundation · 2017 - 2018High Impact Pilot Project on Myasthenia Gravis and Related Neuromuscular Junction Disorders
ResearchSignificant Contributor · Awarded by Myasthenia Gravis Foundation · 2014 - 2017A Consensus Conference on Treatment Guidelines for Myasthenia Gravis (ad hoc)
ConferencePrincipal Investigator · Awarded by Myasthenia Gravis Foundation · 2014 - 2014A trial of mycophenolate mofetil in Myasthenia Gravis
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2002 - 2007Same
ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 20053,4-Diaminopyridine In Lambert-Eaton Syndrome
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1994 - 19983,4,-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1994 - 19973,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1994 - 19973,4-Diaminopyridine In Myasthenia Gravis & Lambert-Eaton S
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1992 - 19933,4-Diaminopyridine In Myasthenia Gravis & Lambert-Eaton
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1991 - 19933,4-Diaminopyridine In Myasthenia Gravis And Lambert-Eaton
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1990 - 1993Supplemental Award
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1990 - 1993External Relationships
- Horizon Therapeutics
- Janssen Pharmaceuticals (Johnson & Johnson)
- Regeneron Pharmaceuticals
- Roche
- Sanofi-Aventis/HSC Acquisitions LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.